Cell and gene therapy validation challenges
Broadcast dateTue, Feb 22, 2022
- Sharif Ahmed - Bayer
With the purpose to highlight some of the challenges in validating cell and gene therapy (CGT) drug substance (DS) and drug product (DP) manufacturing processes and analytical methods, this webinar aims to bring an awareness of the complexity associated with these processes.
Director, Process Validation - Global MSAT-Biotech